Elon Musk’s Neuralink gets FDA approval for human trials: What to know


Neuralink, Elon Musk’s brain-implant company, said Thursday evening that it has regulatory approval to conduct the first clinical trial of its experimental device in humans. Approval by the U.S. Food and Drug Administration would mark a milestone for the company, which has been developing a device surgically inserted into the brain by a robot and capable of decoding brain…

This story appeared on washingtonpost.com, 2023-05-26.
The Web's Most Comprehensive Business News Hub. Free to Use →